| Style | Citing Format |
|---|---|
| MLA | Balighi K, et al.. "Anti-Desmoglein-1 Levels As Predictor of Prednisolone Tapering in Pemphigus Vulgaris Patients Treated With Rituximab." Dermatologic Therapy, vol. 31, no. 6, 2018, pp. -. |
| APA | Balighi K, Sakhi RS, Daneshpazhooh M, Mahmoudi H, Teimourpour A, Tavakolpour S (2018). Anti-Desmoglein-1 Levels As Predictor of Prednisolone Tapering in Pemphigus Vulgaris Patients Treated With Rituximab. Dermatologic Therapy, 31(6), -. |
| Chicago | Balighi K, Sakhi RS, Daneshpazhooh M, Mahmoudi H, Teimourpour A, Tavakolpour S. "Anti-Desmoglein-1 Levels As Predictor of Prednisolone Tapering in Pemphigus Vulgaris Patients Treated With Rituximab." Dermatologic Therapy 31, no. 6 (2018): -. |
| Harvard | Balighi K et al. (2018) 'Anti-Desmoglein-1 Levels As Predictor of Prednisolone Tapering in Pemphigus Vulgaris Patients Treated With Rituximab', Dermatologic Therapy, 31(6), pp. -. |
| Vancouver | Balighi K, Sakhi RS, Daneshpazhooh M, Mahmoudi H, Teimourpour A, Tavakolpour S. Anti-Desmoglein-1 Levels As Predictor of Prednisolone Tapering in Pemphigus Vulgaris Patients Treated With Rituximab. Dermatologic Therapy. 2018;31(6):-. |
| BibTex | @article{ author = {Balighi K and Sakhi RS and Daneshpazhooh M and Mahmoudi H and Teimourpour A and Tavakolpour S}, title = {Anti-Desmoglein-1 Levels As Predictor of Prednisolone Tapering in Pemphigus Vulgaris Patients Treated With Rituximab}, journal = {Dermatologic Therapy}, volume = {31}, number = {6}, pages = {-}, year = {2018} } |
| RIS | TY - JOUR AU - Balighi K AU - Sakhi RS AU - Daneshpazhooh M AU - Mahmoudi H AU - Teimourpour A AU - Tavakolpour S TI - Anti-Desmoglein-1 Levels As Predictor of Prednisolone Tapering in Pemphigus Vulgaris Patients Treated With Rituximab JO - Dermatologic Therapy VL - 31 IS - 6 SP - EP - PY - 2018 ER - |